Skip to main content
. 2020 Jul 24;15(7):e0236361. doi: 10.1371/journal.pone.0236361

Table 1. Primers used for qPCR.

Oligonucleotide 5'-sequence-3'
Slc8a1 forward AGAGCTCGAATTCCAGAACGATG
Slc8a1 reverse TTGGTTCCTCAAGCACAAGGGAG
Trpv5 forward TCCTTTGTCCAGGACTACATCCCT
Trpv5 reverse TCAAATGTCCCAGGGTGTTTCG
Calb1 forward AACTGACAGAGATGGCCAGGTTA
Calb1 reverse TGAACTCTTTCCCACACATTTTGAT
Atp2b4 forward CTTAATGGACCTGCGAAAGC
Atp2b4 reverse ATCTGCAGGGTTCCCAGATA
beta-actin forward GTC CAC CTT CCA GCA GAT GT
beta-actin reverse AGT CCG CCT AGA AGC ACT TGC
Gapdh forward CCA CCC AGA AGA CTG TGG AT
Gapdh reverse CAC ATT GGG GGT AGG AAC AC
Slc34a1 forward TCACAGTCTCATTCGGATTTGG
Slc34a1 reverse GGCCTCTACCCTGGACATAGAA
Slc34a3 forward CCTACCCCCTCTTCTTGGGT
Slc34a3 reverse AGAGCAACCTGAACTGCGAA
Cyp27b1 forward ATGTTTGCCTTTGCCCAGA
Cyp27b1 reverse GACGGCATATCCTCCTCAGG
Cyp24a1 forward GAAGATGTGAGGAATATGCCCTATTT
Cyp24a1 reverse CCGAGTTGTGAATGGCACACT
Ahsg forward CGACAAAGTCAAGGTGTGGTC
Ahsg reverse TCAGCTGCCTCACAGAACAGT
Egf forward GAGTTGCCCTGACTCTACCG
Egf reverse CCACCATTGAGGCAGTATCC
Egfr forward CAGAACTGGGCTTAGGGAAC
Egfr reverse GGACGATGTCCCTCCACTG
Trpm6 forward AAAGCCATGCGAGTTATCAGC
Trpm6 reverse CTTCACAATGAAAACCTGCCC
Trpm7 forward GGTTCCTCCTGTGGTGCCTT
Trpm7 reverse CCCCATGTCGTCTCTGTCGT
HHS Vulnerability Disclosure